CSL Ltd
ASX:CSL
CSL Ltd
Income from Continuing Operations
CSL Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Income from Continuing Operations
$2.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Immutep Ltd
ASX:IMM
|
Income from Continuing Operations
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
Opthea Ltd
ASX:OPT
|
Income from Continuing Operations
-$161.6m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-51%
|
|
Mesoblast Ltd
ASX:MSB
|
Income from Continuing Operations
-$73.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Income from Continuing Operations
AU$30.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Income from Continuing Operations
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CSL Ltd's Income from Continuing Operations?
Income from Continuing Operations
2.5B
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Income from Continuing Operations amounts to 2.5B USD.
What is CSL Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
7%
Over the last year, the Income from Continuing Operations growth was 18%. The average annual Income from Continuing Operations growth rates for CSL Ltd have been -2% over the past three years , 7% over the past five years , and 7% over the past ten years .